ALGN vs CPRX · P/E 35, rev $2.10B vs P/E 18, rev $491.7M
Align Technology Inc (ALGN) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the ALGN and CPRX stock pages for the full models.
Not investment advice.